552 Fully Vaccinated Oregon Residents Died Of COVID-19, Half Received Pfizer Vaccine |
A Novel Practical Approach for Directly Assessing COVID-19 Vaccine Efficacy against Hospitalization |
A Systematic Review of COVID-19 Vaccine-Induced Takotsubo Cardiomyopathy: A 2023 Update |
Acute-onset chronic inflammatory demyelinating polyneuropathy following AstraZeneca COVID-19 vaccine: a case report |
All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25-44 Years, March-July 2020 |
An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021 |
Appendix 1: estimation of number needed to vaccinate to prevent a COVID-19 hospitalisation for primary vaccination, booster vaccination (3rd dose), autumn 2022 and spring 2023 booster for those newly in a risk group |
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link? |
Biden's Bounty on Your Life: Hospitals' Incentive Payments for COVID-19 |
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting |
Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19 |
Case report: Varicella zoster virus encephalitis following COVID-19 vaccination in an immunocompetent individual |
CNS Demyelination Syndromes Following COVID-19 Vaccination: A Case Series |
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence |
Correlation Between 3790 Quantitative Polymerase Chain Reaction - Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates |
Covid Whistleblowers, What the Nurses Saw |
COVID-19 in Northern Ireland: Vaccination Status of Deaths and Hospitalisations — Updated to Include Weeks 51 to 2 (20th December 2021 to 16th January 2022) |
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1 |
Covid-19 Rapport om omikronvarianten |
COVID-19 Vaccination-Induced Cardiomyopathy Requiring Permanent Left Ventricular Assist Device |
COVID-19 Vaccination-Related Myocarditis: What We Learned From Our Experience and What We Need to Do in The Future |
COVID-19 Vaccine Breakthrough Case Investigation and Reporting |
COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021 |
COVID-19 vaccine effectiveness updates - 24 February 2023 (CDC) |
COVID-19 vaccine surveillance report, Week 13 |
COVID-19 vaccine surveillance report, Week 2 |
COVID-19 vaccine surveillance report, Week 48 |
COVID-19 Vaccine-Related Myocarditis: A Descriptive Study of 40 Case Reports |
Current Hospital Capacity Estimates - Snapshot |
Deaths Following C-19 Vaccination: An open letter from NZDSOS on the Need to Investigate Deaths Following Vaccination |
Dr. Peter McCullough presentation at 78th Annual Meeting of Association of American Physicians and Surgeons (AAPS) |
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 |
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections |
Estimated COVID-19 Burden |
Estimating the burden of SARS-CoV-2 in France |
Evaluating Data Integrity and Reporting Challenges in Public Health: Lessons from COVID-19 Data Collection in Washington State |
Frequency and Associations of Adverse Reactions of COVID19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States |
From risk to resilience: An equity approach to COVID-19 - Chief Public Health Officer of Canada's Report on the State of Public Health in Canada 2020 |
Guillain-Barré syndrome associated with SARS-CoV-2 vaccination: how is it different? a systematic review and individual participant data meta-analysis |
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial |
Legal Letter on Behalf of Physicians Regarding Covid-19 Vaccine Injuries (to heads of the DHHS, CDC, and FDA) |
Letter to the Editor: Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections |
Medical Hypothesis: Respiratory epidemics and pandemics without viral transmission |
My Life in the Thrill Kill Medical Cult |
Neurologic Sequela of COVID-19: Guillain-Barré Syndrome Following Johnson & Johnson COVID-19 Vaccination |
New COVID-19 Treatments Add-On Payment (NCTAP) |
NHS key statistics: England |
No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway |
Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021 |
NSW COVID-19 Weekly Data Overview: Epidemiological weeks 51 and 52, ending 31 December 2022 |